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Abstract
The aim of this study was to evaluate the effectiveness of submucosal application of tramadol, for acute postoperative
facial pain, following the extraction of impacted third molar teeth. This prospective, double-blind, randomised
placebo-controlled study included 60 ASA I-II patients undergoing impacted third molar surgery under local
anaesthesia. Following the surgical procedure, patients were randomly divided into two groups; group T (1 mg/kg
tramadol) and group S (2-mL saline). Treatments were applied submucosally after surgery. Pain after extraction was
evaluated using a visual analogue scale (VAS) 0.5, 1, 2, 4, 6, 12, 24, and 48 h postoperatively. The time at which the first
analgesic drug was taken, the total analgesic dose used, and adverse tissue reactions were also evaluated. In group T,
postoperative VAS scores were significantly lower compared to that in group S (p < 0.05). This study demonstrated that
post-operative submucosal application of tramadol is an effective method for reducing acute post-operative facial pain
after impacted third molar surgery.
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Introduction
Tramadol hydrochloride is a centrally acting synthetic
opioid analgesic. Although classified as a weak opioid in
terms of its analgesic properties, tramadol exerts a double
action, functioning as both an opioid and a non-opioid. It
also reduces the transmission of pain impulses by inhibit-
ing serotonin and norepinephrine re-uptake [1], thereby
inducing a combined analgesic/adjuvant effect. The inci-
dence of opioid abuse is very high; the main side-effects
are nausea, vomiting, drowsiness and dizziness. Opioids
also exert a depressive effect on the cardiovascular and re-
spiratory systems [2–4]. Although it is an opioid, tramadol
produces few side-effects; therefore it can be used for both
acute and chronic pain.
Surgical extraction of wisdom teeth is among the most-
frequently performed dental surgical procedures, and is
associated with medium-severe pain. Between 3–5 h after
surgery, the efficacy of local anaesthesia declines and pain
reaches its maximum level [1]. Therefore, for many years
researchers have aimed to identify a more-effective anal-
gesic for application after surgical tooth extraction. The
purpose of this study was to evaluate the effectiveness of
submucosal application of tramadol, for acute postopera-
tive facial pain, following the extraction of impacted third
molar teeth.
Materials & methods
This comparative, prospective, randomised study enrolled
60 patients from the Department of Oral and Maxillofacial
Surgery, Dentistry Faculty, Marmara University, Istanbul,
Turkey. Ethics Committee approval was obtained from the
appropriate institution (Yeditepe University Local Ethics
Committee. Istanbul-Turkey. Approval no. 155/6122011).
Informed consent was obtained from all participants.
To standardise the study, both groups comprised elective
patients who had undergone unilateral mandibular third
molar extraction surgery. All patients were > 18 years of
age, weighed < 100 kg and were classified as ASA I-II using
the guidelines of the American Society of Anesthesiology
[5]. The study used a randomized, double-blind, placebo-
controlled design. The exclusion criteria were use of
sedatives, tranquilisers, or analgesic drugs 24 h before
treatment, a history of sensitivity to tramadol, and the use
of more than three ampoules of local anaesthesia during
the procedure. All of the teeth included to study were me-
sially angulated and completely impacted third molars. A
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simple randomization technique was used to achieve
randomization by using a random number generator.
During surgery, all patients were in the semi-supine pos-
ition. Electrocardiography, non-invasive blood pressure
and peripheral oxygen saturation monitors were firstly at-
tached. Then, an inferior dental nerve block was obtained
using 4 % articaine HCl with 1:100,000 epinephrine HCl
(Ultracaine D-S Forte; Aventis, Bridgewater, NJ, USA).
The efficacy of the local anaesthetic was assessed by verbal
questioning and gentle probing of the buccal and lingual
surfaces of the impacted mandibular third molar which
was removed using standard surgical techniques.
After the extraction of the tooth, patients were ran-
domly divided into two groups: group T (1 mg/kg tram-
adol diluted with saline to 2 mL) and group K (2-mL
saline). The 2 mL volume of solutions were prepared by
an anaesthetic nurse and placed in sterile disposable sy-
ringes. Both the surgeon and the patients were blinded
to the specific solution used. After extraction of the tooth,
the surgeon applied the solution to the extraction socket
and the bone surface by means of small drops. The sur-
geon and the patients were both blinded to the specific so-
lution used. The time at which the local anaesthesia was
applied was defined as time 0; the time at which the ex-
traction procedure started, and the total extraction time,
were also recorded.
The postoperative mean blood pressure, heart rate, per-
ipheral oxygen saturation and Ramsay scores of all
patients were recorded at 10-min intervals. Patients
were questioned about side-effects (burning, nausea, vomit-
ing, weakness and hallucinations) after the procedure.
Pain after extraction was evaluated using a visual
analogue scale (VAS); patients were asked to score overall
pain at 0.5, 1, 2, 4, 6, 12, 24 and 48 h using the VAS (0, no
pain; 5, pain requiring analgesia; 10, excessive pain). Pa-
tients were asked to record the time and amount of
analgesic taken after surgical extraction; total anal-
gesic consumption during the first 48 h was also re-
corded. Data charts were collected from patients at
the end of the follow up period.
The data were analysed using the SPSS for Windows
software package (ver. 16.0; SPSS Inc., Chicago, IL,
USA). Descriptive statistics (mean, standard deviation,
frequency) were obtained and the chi-squared test was
used to compare groups.
Results
A total of 60 patients was included in this study (30 in
each group). The distribution of patients among groups
is shown in Table 1. There were no significant group dif-
ferences in grouping variables, such as the difficulty of
the procedure or duration of extraction. No complica-
tions were associated with the extraction procedure. The
VAS scores of the control group (group S) 1, 2, 4, 6 and
12 h postoperatively, were significantly higher compared
to the tramadol group (group T). There were no signifi-
cant group differences in VAS scores 24 and 48 h post-
operatively (p > 0.05). The first analgesic was taken
Table 1 Patient characteristics, surgery time, total surgery time, visual analogue scale (VAS) scores, analgesic intake
Group S Group T
Mean ± SD Mean ± SD Test Value p
Age (years) 23.93 ± 2.828 24.80 ± 2.524 −1.252 0.215a
Height (cm) 168.13 ± 8.033 168.23 ± 8.705 −0.074 0.941b
Weight (kg) 65.00 ± 10.286 64.93 ± 11.453 −0.603 0.547b
ASA Grade 1.00 ± 0.000 1.00 ± 0.000
Total Surgery Time (min) 48.00 ± 4.185 46.90 ± 4.528 −1.141 0.254b
Surgery Time (min) 26.27 ± 3.591 25.37 ± 3.306 1.01 0.317a
VAS 0.5 h 0.00 ± 0.000 0.00 ± 0.000
VAS 1 h 6.37 ± 0.850 2.23 ± 0.898 −6.755 0.0001b
VAS 2 h 3.63 ± 0.615 1.87 ± 0.819 −6.188 0.0001b
VAS 4 h 3.07 ± 0.691 4.30 ± 1.264 −4.714 0.0001b
VAS 6 h 3.33 ± 1.446 1.77 ± 1.382 −3.849 0.0001b
VAS 12 h 0.63 ± 0.765 1.17 ± 0.791 −2.668 0.008b
VAS 24 h 0.23 ± 0.430 0.10 ± 0.305 −1.374 0.169b
VAS 48 h 0.07 ± 0.254 0.00 ± 0.000 −1.426 0.154b
Initial Analgesic Intake 1.87 ± 0.681 4.97 ± 0.809 −6.779 0.0001b
Total Analgesic Intake 3.60 ± 0.814 1.67 ± 0.547 −6.47 0.0001b
aStudent’s t-test (test value “t”)
bMann-Whitney U test (test value “Z”)
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significantly later in the tramadol group compared to
the control group (p = 0.0001). Total analgesic intake in
the control group was significantly higher (p = 0.0001;
Table 1). Pain peak time for group S was 1 h after oper-
ation and for group T was 4 h after operation (Table 1).
There were no significant group differences in side-
effects (nausea, vomiting, burning, and dizziness; Table 2).
Mean blood pressure, heart rate and peripheral oxygen
saturation are displayed in Table 3. Although there were
significant differences in mean blood pressure and heart
rate between 0 and 30 min, these differences were not
clinically significant.
Discussion
Following impacted third molar surgery, medium-severe
pain occurs during the early postoperative stage. To im-
prove patient satisfaction after dental surgical procedures,
postoperative pain should be reduced. Several studies have
assessed the effectiveness of tramadol application for anal-
gesia after surgery, but few have evaluated submucosal
application. In one study, submucosal tramadol was
administered after paediatric tonsillectomy surgery, which
reduced the need for post-surgical analgesia [6]. In another
study, a combination of tramadol and acetaminophen tab-
lets was used and conferred highly effective analgesia [7].
Collins et al. performed a study assessing the effect of
tramadol for the relief of pain after dentoalveolar opera-
tions. The operations included bone removal and suturing.
At the end of the study, it has been shown that tramadol
was successful in complete pain relief which was contin-
ued for the following 2 days [2]. In a study, they investi-
gated the analgesic effects of tramadol. Tramadol was
given systemically, applied into the surgical site after the
extraction of impacted third molar under local anesthesia.




Group S Group T
n % n %
Gender Female 17 56.70 17 56.70 0.000 1 1.000
Male 13 43.30 13 43.30
Accompanying Disease Absent 30 100.00 30 100.00
Present 0 0.00 0 0.00
Nausea Absent 28 93.30 25 83.30 1.456 1 0.228
Present 2 6.70 5 16.70
Vomiting Absent 28 93.30 30 100.00 2.069 1 0.150
Present 2 6.70 0 0.00
Burning Absent 27 90.00 30 100.00 3.158 1 0.076
Present 3 10.00 0 0.00
Dizziness Absent 30 100.00 30 100.00
Present 0 0.00 0 0.00
aPearson’s chi-squared test
Table 3 Vital Signs of Groups
Group S Group T
Mean ± SD Mean ± SD Test Value p
MBP 0. min 60,10 ± 1,539 61,13 ± 1,717 −2,455 0,017a
MBP 10. min 60,77 ± 1,478 60,73 ± 1,337 −0,008 0,994b
MBP 20. min 60,37 ± 1,450 60,50 ± 1,009 −0,183 0,855b
MBP 30. min 60,60 ± 1,276 61,00 ± 0,910 −1,536 0,125b
MBP 40. min 60,60 ± 1,404 61,03 ± 1,299 −1,24 0,220a
MBP 50. min 60,47 ± 1,306 60,77 ± 1,382 −0,864 0,391a
MBP 60. min 60,57 ± 1,455 60,73 ± 1,413 −0,45 0,654a
HR 0. min 73,37 ± 2,988 73,00 ± 2,994 0,475 0,637a
HR 10. min 73,67 ± 3,427 73,27 ± 3,129 0,472 0,639a
HR 20. min 73,97 ± 3,306 73,83 ± 3,485 0,152 0,880a
HR 30. min 74,27 ± 3,183 72,70 ± 2,215 2,213 0,031a
HR 40. min 74,10 ± 3,377 73,07 ± 3,084 1,238 0,221a
HR 50. min 74,27 ± 3,084 72,90 ± 2,998 1,74 0,087a
HR 60. min 74,10 ± 3,033 74,17 ± 2,829 −0,088 0,930a
SpO2 0. min 98,73 ± 0,450 98,80 ± 0,407 −0,605 0,545b
SpO2 10. min 98,87 ± 0,346 98,77 ± 0,430 −0,993 0,321b
SpO2 20. min 98,87 ± 0,346 98,70 ± 0,466 −1,554 0,120b
SpO2 30. min 98,80 ± 0,407 98,80 ± 0,407 0 1,000b
SpO2 40. min 98,77 ± 0,430 98,63 ± 0,490 −1,117 0,264b
SpO2 50. min 98,83 ± 0,379 98,73 ± 0,450 −0,932 0,351b
SpO2 60. min 98,80 ± 0,407 98,73 ± 0,450 −0,605 0,545b
aStudent’s t-test (test value “t”)
bMann-Whitney U test (test value “Z”)
MBP Mean Blood Pressure, HR Heart Rate, SpO2 Pheripheral Oxygen Saturation
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It has been found that tramadol extends the duration of
anesthesia in both local and systemical administration,
and shown that it improves the quality of postoperative
analgesia [8]. In a comparative study, combinations of 10-
mg oral ketorolac and 50-mg submucosal tramadol, and
10-mg oral ketorolac and saline, were used. The treat-
ments were administered 30 min before the impacted
third molar surgery; combination tramadol treatment was
more effective in reducing post-operative pain and the
total amount of analgesic required [9]. In a comparative
study by Ong et al. (2005), the effectiveness of intravenous
(i.v.) and oral tramadol, after impacted third molar sur-
gery, was compared in patients under sedation (performed
using midazolam). VAS scores were significantly lower,
analgesic intake time was later, and total analgesic intake
48 h post-operatively was reduced, in the i.v. group. Fur-
thermore, single-dose oral tramadol was insufficient for
analgesia after impacted tooth surgery [4]. Another com-
parative, prospective, randomised double-blind study, by
Pozos et al. (2007), compared preoperative and postopera-
tive 100-mg intramuscular tramadol. Preoperative trama-
dol was more effective in reducing postoperative pain
[10]. In an another study, Isıordia Espinoza MA and et al.
compared the pre-emptive analgesic effectiveness of 15 mg
of meloxicam and 50 mg of tramadol after mandibular
third molar surgery at the end of the study they re-
vealed that the patients receiving 15 mg of preopera-
tive meloxicam had less pain intensity and total analgesic
consumption than those receiving 50 mg of preoperative
tramadol [11]. Another double-blind, randomized, placebo-
controlled, crossover clinical trial by Isıordia Espinoza MA
and et al. was performed to evaluate the effect of submu-
cous tramadol as adjuvant of mepivacaine with epinephrine
in inferior alveolar nerve block and stated that submucous
tramadol increased the anesthetic efficacy of mepivacaine
with epinephrine of soft tissue in inferior alveolar nerve
block [12]. Ceccheti MM and et al., conducted a study to
evaluate the analgesic and adjuvant anesthetic effects
of submucosal tramadol after third molar extraction. They
found that submucosal tramadol injection after oral sur-
gery improved postoperative analgesia, but did not extend
anesthetic action duration [13]. In the present study, VAS
scores at 1, 2, 4, 6 and 12 h were significantly lower, first
analgesic intake was significantly later, and total analgesic
intake was significantly lower, in the tramadol group com-
pared to controls.
Conclusion
Submucosal tramadol represents an effective, safe and reli-
able method of reducing postoperative acute facial pain
after impacted third molar surgery. However, further stud-
ies are required to validate the efficacy of submucosal tram-
adol after dental or surgical procedures.
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